MTHFR in Fatigue, Brain Fog, and Athletic Performance

What is MTHFR?

Methylenetetrahydrofolate reductase, usually shortened to MTHFR, is an enzyme involved in folate metabolism and methylation. Methylation is a set of biochemical reactions that helps support DNA synthesis, red blood cell production, neurotransmitter balance, detoxification pathways, amino acid metabolism, cardiovascular health, and normal cellular repair.

MTHFR helps convert folate into 5-methyltetrahydrofolate, also called 5-MTHF. This is the active folate form used to help recycle homocysteine back into methionine. Methionine can then be used to generate S-adenosylmethionine, or SAMe, one of the body's major methyl donors.

In athletic and performance settings, MTHFR is often discussed as a possible contributor to fatigue, brain fog, poor recovery, low mood, or reduced exercise tolerance. That can be true in some cases, but it is often oversimplified. MTHFR variants are common, and many people with MTHFR variants are completely healthy.

The clinically useful question is not simply, "Do I have an MTHFR variant?"

The better question is:

"Is there evidence that folate metabolism, B vitamin status, or homocysteine regulation is actually affecting my symptoms, recovery, or long-term health?"

Why Methylation Matters

Methylation is involved in many normal cellular functions. It helps regulate how the body uses folate and vitamin B12, how homocysteine is recycled, how DNA is synthesized and repaired, how neurotransmitters are metabolized, and how certain detoxification and repair pathways function.

This does not mean methylation is a mysterious or fragile system that needs aggressive supplementation. The body has multiple overlapping pathways for methylation and homocysteine metabolism. Diet, genetics, vitamin status, kidney function, thyroid function, inflammation, medications, alcohol intake, gut health, sleep, and training load can all affect the system.

For many patients, the most practical entry point is homocysteine. Homocysteine is a measurable blood marker that gives more useful information than MTHFR genotype alone. If homocysteine is normal and B vitamin status is adequate, an MTHFR variant may not require any specific intervention.

The Folate, B12, and Homocysteine Pathway

Homocysteine is an amino acid produced during methionine metabolism. The body has several ways to process homocysteine.

One major pathway recycles homocysteine back into methionine. This requires:

• 5-MTHF, the active methylated form of folate
• Vitamin B12, especially in its methylcobalamin cofactor role
• Methionine synthase, the enzyme that transfers the methyl group
• Adequate function of the folate and methylation cycle

Another pathway helps convert homocysteine toward cysteine and glutathione-related metabolism. This pathway depends partly on vitamin B6.

A third support pathway uses betaine, also called trimethylglycine or TMG, to help donate methyl groups through a separate enzyme system. This can become relevant when homocysteine remains elevated despite correcting folate, B12, and riboflavin status.

The MTHFR enzyme sits upstream in this system. It helps generate 5-MTHF, which provides the methyl group needed for homocysteine recycling. If MTHFR activity is reduced and folate status is low, homocysteine may rise.

Common MTHFR Variants

The two most commonly discussed MTHFR variants are C677T and A1298C.

C677T is the variant most strongly linked with reduced MTHFR enzyme activity, especially in people who have two copies of the variant. Riboflavin status can also matter because MTHFR uses riboflavin, or vitamin B2, as part of enzyme function.

A1298C is also common, but it is generally less strongly associated with elevated homocysteine than C677T. Some people carry one copy of one variant, two copies of one variant, or one copy of each. These patterns may affect enzyme activity differently, but genotype alone does not tell the whole story.

Many people with MTHFR variants have normal homocysteine levels, normal blood counts, normal folate status, and no symptoms from the variant. This is why MTHFR testing should not be treated as a diagnosis by itself.

How MTHFR Can Influence Fatigue

Fatigue has many possible causes. MTHFR and methylation pathways may be relevant when fatigue occurs alongside measurable findings such as elevated homocysteine, low or borderline B12, low folate, macrocytosis, anemia patterns, poor dietary intake, high alcohol intake, chronic inflammation, or increased training stress.

When the pathway is under-supported, patients may experience nonspecific symptoms such as low energy, poor recovery, reduced exercise tolerance, low mood, or brain fog. These symptoms are not unique to MTHFR. They can also come from sleep apnea, iron deficiency, thyroid dysfunction, low testosterone, menopause, depression, overtraining, under-fueling, chronic stress, insulin resistance, chronic infection, inflammatory disease, kidney dysfunction, medication effects, and inadequate protein or calorie intake.

This is why the lab pattern matters. A patient with fatigue and elevated homocysteine deserves a different plan than a patient with fatigue, normal homocysteine, untreated sleep apnea, low ferritin, and inadequate carbohydrate intake for training.

MTHFR, Brain Fog, and Neurotransmitter Support

Brain fog can feel like poor focus, word-finding difficulty, low mental stamina, slow processing speed, forgetfulness, or the sense that thinking requires more effort than it should.

Methylation is involved in neurotransmitter metabolism and nervous system function, but brain fog should not automatically be blamed on MTHFR. Sleep disruption, low oxygen during sleep, stress, depression, anxiety, ADHD, post-viral syndromes, thyroid disease, low iron, B12 deficiency, blood sugar swings, medication side effects, alcohol, and chronic pain can all produce similar symptoms.

MTHFR becomes more relevant when brain fog occurs with elevated homocysteine, low or borderline B12, low folate, high methylmalonic acid, macrocytosis, neuropathy symptoms, or a diet pattern that is low in B vitamin intake.

In those cases, treatment may include methylated B12, folate support, riboflavin, food-based nutrition changes, and follow-up labs. The goal is not to overstimulate methylation. The goal is to correct bottlenecks and then reassess symptoms and biomarkers.

MTHFR and Athletic Performance

Athletes and highly active adults place repeated demands on energy production, red blood cell turnover, tissue repair, nervous system function, and recovery. Folate, B12, B6, riboflavin, iron, thyroid hormone, protein intake, and total energy availability all matter in that setting.

MTHFR may influence performance indirectly when methylation or homocysteine metabolism is not well supported. Possible clues include persistent fatigue, slower recovery than expected, poor sleep quality, high perceived exertion, plateaued training adaptation, recurrent soft tissue irritation, unexplained low mood, or brain fog during heavy training blocks.

However, MTHFR is rarely the only issue. Training load, sleep, energy availability, carbohydrate intake, protein intake, iron status, hydration, alcohol use, menstrual health, testosterone status, thyroid function, stress, and cardiometabolic health are often more important and more actionable.

For athletes, the most useful approach is to integrate MTHFR into a broader performance lab review rather than treat it as the central explanation for every symptom.

Homocysteine as a Biomarker

Homocysteine is one of the most practical biomarkers for evaluating whether methylation support may be relevant. It integrates information from folate status, B12 status, B6 status, riboflavin status, thyroid function, kidney function, inflammation, genetics, diet, and lifestyle.

When homocysteine is elevated, the next step is not simply to take a large methylation supplement. The better approach is to identify why homocysteine is elevated.

Important contributors may include:

• Low folate intake
• Low vitamin B12
• Low riboflavin status
• Low vitamin B6
• Kidney dysfunction
• Hypothyroidism
• Smoking
• High alcohol intake
• Certain medications
• Low intake of leafy greens, legumes, eggs, animal proteins, or fortified foods
• Malabsorption or gastrointestinal disease
• Chronic inflammation
• High training stress with poor recovery
• MTHFR C677T, especially when combined with low folate or low riboflavin status

Homocysteine should be interpreted in clinical context. Very high levels require medical evaluation. Mild elevations often improve with correction of nutrition, B vitamins, thyroid status, kidney-related contributors, and lifestyle factors.

What Labs Are Helpful?

A useful workup may include:

• Homocysteine
• Serum B12
• Methylmalonic acid, especially when B12 status is unclear
• Folate or RBC folate
• CBC with MCV to look for anemia or macrocytosis
• Ferritin and iron studies when fatigue or athletic performance is a concern
• TSH, free T4, and sometimes free T3 when thyroid symptoms are present
• CMP to assess kidney and liver function
• hs-CRP or other inflammation markers when clinically relevant
• Vitamin D when fatigue, immune health, or musculoskeletal pain is present
• Fasting glucose, insulin, and hemoglobin A1c when metabolic symptoms are present
• MTHFR genotype only when the result will change the plan

The most important principle is that genotype should not replace biomarkers. A person can have an MTHFR variant without elevated homocysteine. Another person can have elevated homocysteine without a meaningful MTHFR finding.

When MTHFR Testing is Warranted

MTHFR testing is not necessary for everyone with fatigue, brain fog, or poor recovery. It is most useful when the result will change clinical decision-making.

Testing may be reasonable when a patient has:

• Persistently elevated homocysteine without a clear explanation
• A strong family history of premature vascular disease along with abnormal biomarkers
• Recurrent pregnancy loss concerns in a partner context, when coordinated with the appropriate clinician
• Unusual patterns across folate, B12, methylmalonic acid, CBC, and homocysteine
• Symptoms plus biochemical evidence that the methylation pathway may be under-supported
• A need to personalize folate, riboflavin, or B vitamin strategy after standard evaluation

Testing is less useful when it is used as a broad screening test without symptoms, without homocysteine testing, or without a plan for how the result will change care.

MTHFR testing should also not be used as a stand-alone explanation for blood clots, cardiovascular disease, depression, autism, chronic fatigue, infertility, or athletic underperformance. Those conditions require a broader evaluation.

Treating Elevated Homocysteine

When homocysteine is elevated, treatment should be targeted and stepwise.

The first step is to correct the basics:

• Adequate dietary folate from leafy greens, legumes, asparagus, avocado, citrus, and fortified foods when appropriate
• Adequate vitamin B12 from animal foods or supplementation when needed
• Adequate riboflavin from dairy, eggs, meats, almonds, mushrooms, and fortified foods
• Adequate vitamin B6 from poultry, fish, potatoes, chickpeas, bananas, and other foods
• Treatment of hypothyroidism when present
• Review of kidney function
• Reduction of smoking and excess alcohol
• Review of medications that may affect folate or B vitamin status

Supplementation may include methylcobalamin, methylfolate, riboflavin, and sometimes pyridoxal-5-phosphate or other forms of B6. Dosing should be individualized. More is not always better.

Methylated B12

Methylcobalamin is a methylated form of vitamin B12 that participates in homocysteine recycling through methionine synthase. It is commonly used when the goal is to support methylation and homocysteine metabolism.

Cyanocobalamin can also raise B12 levels and is effective for many people, but it must be converted into active coenzyme forms before use in certain pathways. Methylcobalamin is already in a form used by the methionine synthase reaction, which is why it is commonly selected in methylation-focused care.

B12 status should be interpreted carefully. A normal serum B12 does not always rule out functional B12 insufficiency. Methylmalonic acid can be helpful when B12 status is uncertain, especially in patients with neuropathy symptoms, macrocytosis, strict vegan diets, metformin use, acid-suppressing medications, gastrointestinal disease, or prior bariatric surgery.

Methylfolate

Methylfolate, or 5-MTHF, is the active folate form produced downstream of MTHFR. In patients with MTHFR variants and elevated homocysteine, methylfolate may be a reasonable option because it bypasses the MTHFR conversion step.

However, methylfolate should be dosed thoughtfully. Some patients feel overstimulated, anxious, irritable, or have sleep disruption when starting too high. Others tolerate it well. Starting low and adjusting based on symptoms and labs is often more practical than using high-dose methylfolate by default.

Patients should also avoid assuming that methylfolate alone fixes every methylation issue. B12, riboflavin, B6, thyroid function, kidney function, inflammation, diet, and recovery all matter.

Riboflavin

Riboflavin, or vitamin B2, is especially relevant for MTHFR C677T. MTHFR uses FAD, a riboflavin-derived cofactor. Research suggests that riboflavin supplementation can lower homocysteine in people with the MTHFR 677TT genotype, particularly when riboflavin status is low.

This makes riboflavin a practical and often overlooked part of MTHFR care. It is not a stimulant and is generally well tolerated at common nutritional doses. It may be especially relevant when homocysteine remains elevated despite adequate folate and B12 support.

Vitamin B6

Vitamin B6 supports the transsulfuration pathway, which helps convert homocysteine toward cysteine and glutathione-related metabolism. It may be useful in selected patients, but chronic high-dose B6 should be avoided because excessive B6 intake can cause neuropathy.

This is one reason supplement labels matter. Many methylation products contain overlapping B vitamin doses. Patients may unknowingly take multiple products that together create a much higher B6 intake than intended.

Betaine, or Trimethylglycine

Betaine, also called trimethylglycine or TMG, can support an alternate pathway for homocysteine remethylation. This pathway does not rely on MTHFR in the same way as the folate-dependent pathway.

Betaine may be considered when homocysteine remains elevated after addressing folate, B12, riboflavin, B6, thyroid status, kidney function, and lifestyle factors. It is not a default supplement for everyone with an MTHFR variant.

In selected patients, betaine can be useful. But it should be used with a clear goal, appropriate dosing, and follow-up testing.

Why Large "Methylation Stacks" can Backfire

A common mistake is to start multiple methylated products at once and then assume every symptom change is meaningful. This can create confusion.

Some patients feel overstimulated, anxious, wired, irritable, or have sleep disruption when starting high-dose methylfolate, methylated B12, or multi-ingredient methylation products. Others may develop nausea, headaches, or a sense of being "revved up." These responses do not necessarily mean the supplement is harmful, but they often mean the plan is too aggressive or poorly matched.

The better strategy is to identify the measurable problem, correct the most likely bottlenecks, introduce one change at a time when possible, and repeat labs. This makes it much easier to know what helped.

Nutrition Foundations

Nutrition is the foundation of methylation support. Supplements can help when there is a clear need, but food patterns matter.

Helpful foods may include:

• Leafy greens for folate
• Beans and lentils for folate and magnesium
• Eggs for choline and B vitamins
• Fish, poultry, meat, and dairy for B12 and B6
• Dairy, eggs, almonds, mushrooms, and meats for riboflavin
• Beets, spinach, quinoa, and seafood for betaine and related nutrients
• Protein-rich foods to support amino acid metabolism and recovery

Athletes should also make sure they are eating enough total calories and carbohydrates to match training demands. Under-fueling can worsen fatigue, sleep disruption, hormone changes, poor recovery, and perceived brain fog, regardless of MTHFR status.

MTHFR and Cardiovascular Risk

MTHFR is often discussed online as a major cardiovascular risk gene. The reality is more nuanced.

Elevated homocysteine can be associated with cardiovascular risk, but MTHFR genotype by itself is not usually enough to define risk or guide treatment. Cardiovascular risk assessment should focus on blood pressure, ApoB or LDL cholesterol, insulin resistance, diabetes risk, smoking, inflammatory disease, kidney function, sleep apnea, family history, body composition, exercise capacity, and other established risk factors.

When homocysteine is elevated, it is reasonable to address it. But treating homocysteine should be part of a broader cardiovascular prevention plan, not a replacement for lipid management, blood pressure control, glucose control, sleep apnea treatment, smoking cessation, and exercise.

MTHFR and Pregnancy Considerations

MTHFR is frequently discussed in the context of pregnancy, miscarriage, and neural tube defect risk. This topic should be handled carefully and coordinated with an OB/GYN, maternal-fetal medicine specialist, or fertility clinician when appropriate.

Folate status matters for pregnancy. Adequate folate before and during early pregnancy helps reduce neural tube defect risk. Some patients with MTHFR variants may prefer methylfolate rather than folic acid, but the larger clinical priority is ensuring adequate folate status and appropriate prenatal care.

MTHFR genotype alone should not be used to diagnose a pregnancy problem or to prescribe anticoagulation. Recurrent pregnancy loss, clotting risk, and fertility concerns require a broader evaluation.

A Practical Clinical Approach

A practical approach to MTHFR, fatigue, brain fog, and performance usually follows this sequence:

1. Clarify the symptoms.
   Fatigue, brain fog, poor recovery, low mood, poor sleep, and reduced training tolerance can come from many causes.
2. Review the foundations.
   Sleep, training load, protein intake, carbohydrate intake, total calories, hydration, alcohol, stress, medications, and recovery should be reviewed.
3. Check functional labs.
   Homocysteine, B12, methylmalonic acid, folate, CBC, ferritin, thyroid markers, kidney function, inflammation markers, and metabolic labs can help identify what is actually abnormal.
4. Use MTHFR testing selectively.
   Genetic testing is most useful when homocysteine or related biomarkers suggest a methylation issue and the result will guide treatment.
5. Treat the bottleneck.
   This may include methylated B12, methylfolate, riboflavin, B6, betaine, dietary changes, thyroid optimization, kidney evaluation, or medication review.
6. Avoid over-supplementation.
   More methyl donors are not always better. Start with the minimum effective plan and adjust based on symptoms and follow-up testing.
7. Recheck.
   Homocysteine and related labs should be repeated after an appropriate interval to confirm that the plan is working.

A Better Way To Think About MTHFR

MTHFR variants are common. They are not, by themselves, a performance diagnosis, fatigue diagnosis, or brain fog diagnosis. The most useful approach is to look for functional consequences, especially homocysteine elevation and B vitamin insufficiency.

When those signals are present, targeted support can be helpful. Methylated B12, methylfolate, riboflavin, B6, nutrition changes, and sometimes betaine can be used thoughtfully. But the plan should be based on symptoms, labs, diet, training load, and medical context.

At the Performance Medicine Institute, we take a comprehensive approach to fatigue, brain fog, and athletic performance by combining lab evaluation, nutrition review, body composition testing, exercise and recovery planning, hormone and metabolic assessment, and individualized supplementation when appropriate. Contact us to schedule an evaluation.

References

• Froese DS, Fowler B, Baumgartner MR. Vitamin B12, folate, and the methionine remethylation cycle-biochemistry, pathways, and regulation. J Inherit Metab Dis. 2019;42(4):673-685.
• Hickey SE, Curry CJ, Toriello HV. ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing. Genet Med. 2013;15(2):153-156.
• McNulty H, Dowey le RC, Strain JJ, et al. Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism. Circulation. 2006;113(1):74-80.
• Moll S, Varga EA. Homocysteine and MTHFR mutations. Circulation. 2015;132(1):e6-e9.
• Rozen R. Genetic polymorphisms of folate and cobalamin metabolism. In: Bailey LB, ed. Folate in Health and Disease. 2nd ed. CRC Press; 2009.
• Tsang BL, Devine OJ, Cordero AM, et al. Assessing the association between the methylenetetrahydrofolate reductase 677C>T polymorphism and blood folate concentrations: a systematic review and meta-analysis. Am J Clin Nutr. 2015;101(6):1286-1294.
• Yadav U, Kumar P, Gupta S, Rai V. Distribution of MTHFR C677T gene polymorphism in healthy North Indian population and an updated meta-analysis. Indian J Clin Biochem. 2017;32(4):399-410.